Objective: Owing to the relationship between nitric oxide related endothelial dysfunction, insulin resistance and cardiovascular disease in overweight individuals, we investigated if skeletal muscle endothelial nitric oxide synthase (eNOS) protein content and activity are lower in overweight than lean women. Design: A total of 19 women (age 26.071.7 years) underwent a resting muscle biopsy, body composition analysis by hydrostatic weighing and peak aerobic capacity determination using indirect calorimetry (Study 1). An additional separate set of six lean (p25% fat) and six overweight (425% fat) women were subsequently studied for the determination of eNOS activity, and to better control for absolute peak aerobic capacity between lean and overweight women (Study 2). Results: Skeletal muscle eNOS content was inversely related to percent body fat (r 2 ¼ 0.58, Po0.01), and body mass index (r 2 ¼ 0.35, Po0.05). Total eNOS activity was lower in overweight than lean women (2.0970.22 vs 1.4470.17 U, Po0.05; n ¼ 12), and was inversely related to percent body fat (r 2 ¼ 0.32, P ¼ 0.05), and BMI (r 2 ¼ 0.41, Po0.05). Absolute and relative aerobic capacity were not independent predictors of skeletal muscle eNOS content (r 2 ¼ 0.11 and 0.26, respectively). Conclusion: There is an inverse relationship between eNOS and percent body fat that may have implications for the previously reported reduced endothelial function and insulin sensitivity in overweight women.
Introduction
Obesity and the concurrent metabolic syndrome are often associated with impaired endothelial function, resulting in reduced blood flow, insulin resistance and cardiovascular disease. [1] [2] [3] The constitutively expressed endothelial nitric oxide synthase (eNOS) catalyzes the formation of nitric oxide and L-citrulline from L-arginine. Nitric oxide has many physiological functions in skeletal muscle, including vasodilatation, alterations in capillary permeability and increased glucose uptake. [4] [5] [6] [7] [8] We have previously reported that nutritive flow in skeletal muscle is directly related to the protein content of eNOS in skeletal muscle homogenates from young and older women. 9 A secondary finding of that study was that eNOS protein content was inversely related to body mass index, an indirect measure of body composition. Furthermore, body mass index and waist circumference were the only independent predictors of eNOS content despite inclusion of many other variables previously suggested to be related to endothelial function such as aerobic capacity, plasma estrogen concentration, blood pressure and age. It therefore appears that eNOS protein content is inversely related to general indices of increased body fat; however, body fat and eNOS activity were not specifically measured in this previous study. The purpose of this investigation was therefore to determine if skeletal muscle eNOS content is related to body composition as measured using a better indicator of body composition, for example, hydrostatic weighing, in young women. It was hypothesized that skeletal muscle eNOS protein content and activity would be lower in overweight than lean women.
Methods

Subjects
A total of 19 healthy young (20-40 years) women participated in the initial study of eNOS protein content (Study 1). An additional six lean (p25% fat) and six overweight (425% fat) women were subsequently studied for the determination of eNOS activity, and to better control for absolute peak aerobic capacity between lean and overweight women (Study 2). A 25% body fat cutoff was used as a criteria for overweight because a body fat of greater than 25% is considered above the optimal range for young adult women and indicates increased cardiovascular and metabolic disease risk. 10 These female subjects had regular menses for the past year, and were studied in the late-follicular phase of the menstrual cycle as determined by questionnaire. Subjects were not taking medications that may affect central or peripheral circulation, did not smoke, were not hypertensive (systolic blood pressure4140 mmHg, diastolic blood pressure 490 mmHg), and did not have diabetes, cardiovascular disease, angina or any disease state that may affect central or peripheral circulation. Subjects provided informed consent prior to participating in the study according to the University Medical Committee Institutional Review Board at East Carolina University.
Protocol
Subjects initially underwent body composition analysis 11 and assessment of peak aerobic capacity. Between days 3 and 8 following these initial assessments, subjects reported to the Human Performance Laboratory at East Carolina University for a muscle biopsy. Subjects reported to the laboratory after an overnight fast. A percutaneous muscle biopsy was then obtained for determination of eNOS protein content.
Muscle biopsy
A muscle biopsy was obtained from the vastus lateralis of the quadriceps femoris muscle group. For this, local anesthesia (3.0 cc of 2% lidocaine) was administered subcutaneously above the muscle fascia in the vastus lateralis approximately 1/3 of the distance between the lateral femoral condyle and the iliac crest. A small B6 mm incision was made through which a 5 mm diameter Bergstrom biopsy needle was inserted. A muscle biopsy (approximately 30-50 mg) was clipped and removed from the vastus lateralis. The muscle was frozen under liquid nitrogen and stored for subsequent analysis of eNOS protein content.
Body composition
Residual volume was determined by the oxygen dilution method as described by Wilmore.
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Body density was determined by hydrostatic weighing taking into account the measured residual volume, the weight of the subject in air and in water, as well as the density of water. Percent body fat was calculated from body density using the following equation % fat ¼ (457/body density)À414.2 of Brozek et al. 11 The test-retest reliability in our laboratory is 71.3% fat.
Peak oxygen consumption (VO 2peak )
Peak aerobic capacity was determined on an electronicallybraked cycle ergometer (Lode, Gröningen, Netherlands). The cycle ergometer test was incremental, beginning with a 3-min stage at 25 Watts, followed by a 3-min stage at 50 Watts and subsequent 1-min stages increasing in intensity by 20-Watt increments. Respiratory gases were analyzed continuously and averaged over 20-s intervals using a Sensormedics 2900 Metabolic Measurement Cart (Anaheim, CA). The subjects exercised until they could no longer maintain a cadence of 40 revolutions per minute. Achievement of VO 2peak was determined by attainment of two of the following criteria: (1) plateau in oxygen consumption with increased exercise intensity, (2) respiratory exchange ratio (RER)41.1 and (3) heart rate greater than 85% age-predicted maximal heart rate.
Muscle eNOS analysis
Muscle eNOS was analyzed in whole homogenates using the Quantikine human eNOS kit (R & D Systems, Minneapolis, MN). This assay employs the quantitative sandwich enzyme immunoassay technique. The homogenate was centrifuged at 3000 g for 5 min. The supernatant was poured off. Cells were washed two times in a saline solution. After each wash, they were centrifuged at 3000 g for 5 min. The supernatant was poured off. Cells were lysed at 2-81C with the cell lysis buffer. Cells were centrifuged was 3000 g for 5 min. The supernatant was immediately removed and cells were assayed. In all, 100 ml of the assay diluent RD1W was added to each well of the plate. In all, 100 ml of the standard or sample was added to each well. These were incubated for 2 h at room temperature on a horizontal orbital microplate shaker. After incubation each well was aspirated and washed with 400 ml of buffer. This was repeated for a total of three washings. 200 ml of the eNOS conjugate was added to each well and was incubated for 2 h at room temperature on the shaker. The aspiration/wash procedure was repeated three times. In all, 200 ml of the substrate solution was added to each well and was incubated for 30 min at room temperature. In all, 50 ml of stop solution was added to each well. The optical density of each well was then determined within 30 min using a microplate reader at 450 nm. The coefficient of variation of duplicate eNOS determinations was 5.9%.
ENOS activity was determined using a nitric oxide synthase assay kit (Calbiochem, San Diego, CA). Briefly, 10 ml of muscle biopsy homogenate was added to 40 ml of the provided reaction mixture (Tris-HCL buffer, 10 mM NADPH, 6 mM CaCl 2 , calmodulin and 3 H-Arginine). Aminoguanidine (a specific inhibitor of inducible nitric oxide synthase (iNOS)), and trimethylphenylfluoroimidazole (selective nNOS inhibitor that is 34 times more selective for nNOS than eNOS 13 ), were added to the reaction mixture to eliminate a possible contribution of iNOS and nNOS to the results. L-NMMA (a nonspecific NOS inhibitor), was added to the reaction mixture to serve as a negative control. Human
Body composition and eNOS RC Hickner et al umbilical vein endothelial cells were used as a positive control. Incubation proceeded for 60 min at 371C. 400 ml of stop buffer and 100 ml of equilibrated resin was then be added to the reaction sample. Samples were centrifuged at 3000 g for 30 s. The eluate was then transferred to a vial containing scintillation fluid for counting. eNOS activity results are reported as the ratio of reacted-to-unreacted 3 H-L-arginine.
Statistical analyses
Multiple stepwise correlation analysis was performed to determine the relationship between muscle biopsy eNOS content, percent body fat, peak aerobic capacity and age. Non-linear regression analysis was used to determine the regression equation for the relationship between eNOS content and percent body fat, body mass index or VO 2 peak. A nonpaired Student's t-test was conducted in Study 2 to determine differences in VO 2peak and eNOS activity between overweight and lean women. All statistical analyses were performed using SigmaStat software (Jandel Scientific, La Jolla, CA). The level of significance was set at Po0.05. Data are presented as mean7s.e.m.
Results
Subject characteristics
Subject characteristics are presented in Table 1 . The overweight women in Study 1 had a lower absolute VO 2peak (l/min) than the lean women. For both Study 1 and 2 the overweight women were of similar age, but possessed higher body fat and therefore lower relative VO 2peak (per kilogram lean body mass), than lean women. Absolute VO 2peak (l/min) was not different between lean and overweight women in Study 2.
Muscle eNOS content Study 1. Skeletal muscle eNOS protein content was 40% lower in overweight than lean women (464.9765.8 vs 744.7764 pg/mg total protein content, Po0.05; Figure 1 ).
Skeletal muscle eNOS protein content was inversely related to percent body fat (r 2 ¼ 0.58, Po0.01; Figure 2 ). Aerobic capacity, whether expressed in absolute or relative terms, was not an independent predictor of skeletal muscle eNOS content (r 2 ¼ 0.11 and 0.26, respectively; Figure 3 ). was measured in whole homogenates from muscle biopsies obtained from the vastus lateralis of the quadriceps femoris muscle group from premenopausal women (n ¼ 19) under resting conditions. Body composition was assessed by hydrostatic weighing.
Body composition and eNOS RC Hickner et al Study 2. Similar to Study 1, there was a 40% lower eNOS protein content in overweight than lean women in Study 2. There was a 30% lower total eNOS activity in overweight than lean women in Study 2 (1.4470.17 vs 2.1070.22; Figure 4a ). There was a positive correlation between eNOS protein content and eNOS activity (r 2 ¼ 0.29, Po0.05).
Skeletal muscle eNOS activity was inversely related to percent body fat (r 2 ¼ 0.32, Po0.05), but was not correlated with aerobic capacity. The difference in eNOS activity between overweight and lean women was not evident when the activity data were expressed relative to eNOS protein content (Figure 4b , P ¼ NS).
Discussion
This is the first demonstration to our knowledge that eNOS protein content in muscle homogenates is related to percent body fat. Furthermore, aerobic capacity was not an independent predictor of skeletal muscle eNOS protein content in the healthy young women studied. These data extend our previous findings in a study of pre-and postmenopausal women that eNOS protein content was inversely related to body mass index. 9 Our previous study of eNOS protein content in women focused on resting skeletal muscle nutritive flow, demonstrating that eNOS protein content was positively correlated to skeletal muscle nutritive flow. 9 A secondary finding of that investigation was that eNOS protein content was negatively correlated with body mass index in a group of pre-and postmenopausal women. Furthermore, indirect measures of body composition were the only independent predictors of eNOS content despite inclusion of many other variables previously suggested to be related to endothelial function such as aerobic capacity, plasma estrogen concentration, blood pressure and age. The present study was initiated to determine if eNOS protein content was related to a more rigorous measure of body composition within a more homogeneous group (all premenopausal) of women. Multiple regression analysis in the present study yielded a strong negative relationship between eNOS protein content and body fat percentage as measured using hydrostatic weighing: body fat percentage accounted for a high percentage (58%) of the variance in eNOS protein content. The total eNOS activity was also found to be lower in overweight than lean women (Study 2, Figure 4a) ; however, this difference was not evident when the data were presented relative to the total eNOS protein content (Figure 4b ). The lower total eNOS activity in overweight women studied under the conditions Body composition and eNOS RC Hickner et al of this study therefore appears to be due to differences in total eNOS protein content rather than altered regulation of eNOS activity. Given the myriad of actions that nitric oxide has on muscle blood flow and metabolism, these reports of reduced eNOS protein content in overweight women indicate that nitric oxide produced via eNOS may be related to the previously reported poor metabolic and circulatory profile in women with increased body fat percentage. This is consistent with previous findings that there is a grouping of risk factors within the metabolic syndrome that are related to poor endothelium-dependent vasodilatation. [1] [2] [3] 14, 15 This reduction in eNOS content in obesity cannot be generalized to all tissues, as eNOS protein content is higher in adipose tissue from obese than lean individuals. The reduction in eNOS content of muscle is therefore not likely due to a systemic factor, nor is it likely due to a higher intramuscular lipid content in obese than lean individuals. It might be argued that overweight individuals have a lower percentage of Type 1 fibers and capillary density than lean individuals, and that eNOS protein content is lower in overweight than lean women because of reduced capillarity. However, capillarity and Type 1 fiber percentage would be expected to be more related to peak aerobic capacity and training status. We have previously demonstrated that aerobic capacity is well correlated to capillary density in obese and lean individuals. 16 Body composition, rather than peak aerobic capacity, was the only independent predictor of eNOS protein content in this and our previous study of eNOS. 9 It is therefore unlikely that the lower eNOS protein content in the women with higher body fat percentage was primarily due to a lower capillarity. In summary, skeletal muscle eNOS protein content and activity are inversely related to body fat percentage in young women. The reduced eNOS protein content with increased adiposity may play an important role in the development of cardiovascular and metabolic disease risk in overweight women.
